MLSS Milestone Scientific
- 0.6900
- +0.0107+1.58%
Milestone Scientific News
Express News | Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
Express News | Milestone Scientific Q1 Gross Profit USD 1.7 Million
Express News | Milestone Scientific Q1 Revenue USD 2.2 Million
Press Release: Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024 Sales through new online portal increase 31% over the same period last year Gross marg
Milestone Scientific | 10-Q: Quarterly report
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that
Milestone Scientific Commences Sales of CompuFlo Epidural Disposables Within PRC Alliance Pain Relief Center in Ormond Beach, Florida
PRC Alliance Pain Relief Center operates 8 locations across central Florida Dr. Bakshi reports 100% success performing Epidural Steroid Injection (ESI) procedures during evaluation period ROSELAND, N.J., April 03,
Milestone Scientific: A Strong Buy on Robust Financials and Market Expansion Potential
Milestone Scientific Inc. (AMEX:MLSS) Q4 2023 Earnings Call Transcript
Q4 2023 Milestone Scientific Inc Earnings Call
Earnings Call Summary | Milestone Scientific(MLSS.US) Q4 2023 Earnings Conference
The following is a summary of the Milestone Scientific Inc. (MLSS) Q4 2023 Earnings Call Transcript:Financial Performance:Milestone Scientific reported a 12% increase in revenue for 2023, reaching $9.
Milestone Scientific GAAP EPS of -$0.10, Revenue of $9.83M
Express News | Milestone Scientific Q4 EPS $(0.03) Down From $(0.02) YoY, Sales $2.26M Vs. $2.24M Last Year
Milestone Scientific Had Cash, Cash Equivalents and Marketable Securities of $6M at Dec 31 >MLSS
Milestone Scientific Had Cash, Cash Equivalents and Marketable Securities of $6M at Dec 31 >MLSS
Milestone Scientific FY23 Rev $9.8M >MLSS
Milestone Scientific FY23 Rev $9.8M >MLSS
Press Release: Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023 Reports acceleration of reimbursement claims submission for the CompuFlo(R) Epidural Sys
Earnings Scheduled For April 1, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. • Sharps Technology (NASDAQ:STSS) is
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced
Express News | Milestone Scientific Commences Sales Of CompuFlo To Omaha Pain Physicians
Milestone Scientific Commences Sales of CompuFlo Epidural Disposables Within Omaha Pain Physicians
ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that
Analysis
Price Target
No Data
